Healthcare · Pharmaceuticals & Biotechnology
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 3,876† | 4,416† | 3,674† | 2,436† | 1,862† |
| Net profit | 1,282 | 1,850 | 1,307 | 637 | 139† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| LINGARAO DONTHINENI | Executive Director | June 30, 2026 |
| RAJEEV NANNAPANENI | Executive Director | June 30, 2026 |
| SIVARAMAKRISHNA PRASAD POTLURI | Executive Director | June 30, 2026 |
| VENKAIAH CHOWDARY NANNAPANENI | Executive Director | June 30, 2026 |
| AGNIHOTRA DAKSHINA MURTY CHAVALI | Independent Director | June 30, 2026 |
| DRONADULA VIJAYA BHASKAR | Independent Director | June 30, 2026 |
| LAKSHMINARAYANA BOLISETTY | Independent Director | June 30, 2026 |
| NITIN JAIN | Independent Director | June 30, 2026 |
| SUMA KANTIPUDI | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
